Protein regulation in signal transduction

Cold Spring Harbor Perspectives in Biology

Volumn 8, Issue 6, 2016, Pages

  Lee, Michael J ^a   Yaffe, Michael B ^a  

^a Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE; LIPID; PROTEASOME; PROTEIN BINDING; TRANSCRIPTION FACTOR;

ALLOSTERIC SITE; ANIMAL; CELL MEMBRANE; CHEMISTRY; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; THEORETICAL MODEL; UBIQUITINATION;

ALLOSTERIC SITE; AMINO ACID MOTIFS; ANIMALS; CELL MEMBRANE; GENE EXPRESSION REGULATION; GTP PHOSPHOHYDROLASES; HUMANS; LIPIDS; MODELS, THEORETICAL; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN DOMAINS; PROTEIN INTERACTION MAPPING; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UBIQUITINATION;

EID: 84973124477     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a005918     Document Type: Article

References (83)

1. Alexander J, Lim D, Joughin BA, Hegemann B, Hutchins JRA, Ehrenberger T, Ivins F, Sessa F, Hudecz O, Nigg EA, et al. 2011. Spatial exclusivity combined with positive and negative selection of phosphorylation motifs isthebasisforcontext-dependentmitotic signaling. Sci Signal 4: ra42.
2. Ambros V. 2001. microRNAs: Tiny regulators with great potential. Cell 107: 823-826.
3. Ambros V. 2011. MicroRNAs and developmental timing. Curr Opin Genet Dev 21: 511-517.
4. Azeloglu EU, Iyengar R. 2014. Signaling networks: Information flow, computation, and decision making. Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a005934.
5. Bieging KT, Attardi LD. 2012. Deconstructing p53 transcriptional networks in tumor suppression. Trends Cell Biol 22: 97-106.
6. Bivona TG, Pérez De Castro I, Ahearn IM, Grana TM, Chiu VK, Lockyer PJ, Cullen PJ, Pellicer A, Cox AD, Philips MR. 2003. Phospholipase Cg activates Ras on the Golgi apparatus by means of RasGRP1. Nature 424: 694-698.
7. Bos JL, Rehmann H, Wittinghofer A. 2007. GEFs and GAPs: Critical elements in the control of small G proteins. Cell 129: 865-877.
8. Boutin JA. 1997. Myristoylation. Cell Signal 9: 15-35.
9. Brown CJ, Lain S, Verma CS, Fersht AR, Lane DP. 2009.Awakening guardian angels: Drugging the p53 pathway. Nat Rev Cancer 29: 862-873.
10. Burnett G, Kennedy EP. 1954. The enzymatic phosphorylation of proteins. J Biol Chem 211: 969-980.
11. Cantrell D. 2014. Signaling in lymphocyte activation. Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a018788.
12. Casey PJ. 1995. Protein lipidation in cell signaling. Science 268: 221-225.
13. Chen ZJ. 2005. Ubiquitin signalling in the NF-kB pathway. Nat Cell Biol 7: 758-765.
14. Chuderland D, Konson A, Seger R. 2008. Identification and characterization of a general nuclear translocation signal in signaling proteins. Mol Cell 31: 850-861.
15. Chung KY, Rasmussen SGF, Liu T, Li S, Devree BT, Chae PS, Calinski D, Kobilka BK, Woods VL, Sunahara RK. 2011. Conformational changes in the G protein Gs induced by the b2 adrenergic receptor. Nature 477: 611-615.
16. Ciechanover A. 2012. Intracellular protein degradation: Fromavague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Biochim Biophys Acta 1824: 3-13.
17. Dias WB, Cheung WD, Hart GW. 2012. O-GlcNAcylation of kinases. Biochem Biophys Res Commun 422: 224-228.
18. Di Guglielmo GM, Baass PC, Ou WJ, Posner BI, Bergeron JJ. 1994. Compartmentalization of SHC, GRB2 and mSOS, and hyperphosphorylation of Raf-1 by EGF but not insulin in liver parenchyma. EMBO J 13: 4269-4277.
19. Dohlman HG, Jones JC. 2012. Signal activation and inactivation by the Ga helical domain: A long-neglected partner in G protein signaling. Sci Signal 5: re2-re2.
20. Duronio RJ, Xiong Y. 2013. Signaling pathways that control cell proliferation. Cold Spring Harb Perspect Biol 5: a008904.
21. Elion EA. 2001. The Ste5p scaffold. J Cell Sci 114: 3967-3978.
22. Engström W, Ward A, Moorwood K. 2010. The role of scaffold proteins in JNK signalling. Cell Prolif 43: 56-66.
23. Filippakopoulos P, Picaud S, Mangos M, Keates T, Lambert J-P, Barsyte-Lovejoy D, Felletar I, Volkmer R, Müller S, Pawson T, et al. 2012. Histone recognition and large-scale structural analysis of the human bromodomain family. Cell 149: 214-231.
24. Foster MW, Hess DT, Stamler JS. 2009. Protein S-nitrosylation in health and disease: A current perspective. Trends Mol Med 15: 391-404.
25. Gingras AC, Gygi SP, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF, Aebersold R, Sonenberg N. 1999. Regulation of 4E-BP1 phosphorylation: A novel two-step mechanism. Genes Dev 13: 1422-1437.
26. Hara K, Yonezawa K, Kozlowski MT, Sugimoto T, Andrabi K, Weng QP, Kasuga M, Nishimoto I, Avruch J. 1997. Regulation of eIF-4E BP1 phosphorylation by mTOR. J Biol Chem 272: 26457-26463.
27. Heldin C-H, Lu B, Evans R, Gutkind JS. 2014. Signals and receptors. Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a005900.
28. Hepler JR, Gilman AG. 1992. G proteins. Trends Biochem Sci 17: 383-387.
29. Hershko A, Ciechanover A. 1998. The ubiquitin system. Annu Rev Biochem 67: 425-479.
30. Hung MC, Link W. 2011. Protein localization in disease and therapy. J Cell Sci 124: 3381-3392.
31. Ikeda F, Dikic I. 2008. Atypical ubiquitin chains: New molecular signals. EMBO Rep 9: 536-542.
32. Jin J, Pawson T. 2012. Modular evolution of phosphorylation-based signalling systems. Philos Trans R Soc B Biol Sci 367: 2540-2555.
33. Kirkin V, Dikic I. 2007. Role of ubiquitin-and Ubl-binding proteins in cell signaling. Curr Opin Cell Biol 19: 199-205.
34. Kötting C, Kallenbach A, Suveyzdis Y, Wittinghofer A, Gerwert K. 2008. The GAP arginine finger movement into the catalytic site of Ras increases the activation entropy. Proc Natl Acad Sci 105: 6260-6265.
35. Krebs EG, Fischer EH. 1956. The phosphorylase b to a converting enzyme of rabbit skeletal muscle. Biochim Biophys Acta 20: 150-157.
36. Laplante M, Sabatini DM. 2012. mTOR signaling in growth control and disease. Cell 149: 274-293.
37. Lefkowitz RJ, Shenoy SK. 2005. Transduction of receptor signals by b-arrestins. Science 308: 512-517.
38. Letunic I, Doerks T, Bork P. 2011. SMART 7: Recent updates to the protein domain annotation resource. Nucleic Acids Res 40: D302-D305.
39. Levene PA, Alsberg CL. 1906. The cleavage products of vitellin. J Biol Chem 2: 127-133.
40. Lim KH, Staudt LM. 2013. Toll-like receptor signaling. Cold Spring Harb Perspect Biol 5: a011247.
41. Lima B, Forrester MT, Hess DT, Stamler JS. 2010. S-Nitrosylation in cardiovascular signaling. Circ Res 106: 633-646.
42. Lipmann FA, Levene PA. 1932. Serinephosphoric acid obtained on hydrolysis of vitellinic acid. J Biol Chem 98: 109-114.
43. Lowery DM, Lim D, Yaffe MB. 2005. Structure and function of Polo-like kinases. Oncogene 24: 248-259.
44. Lynch KW. 2007. Regulation of alternative splicing by signal transduction pathways. Adv Exp Med Biol 623: 161-174.
45. Macdonald N, Welburn JPI, Noble MEM, Nguyen A, Yaffe MB, Clynes D, Moggs JG, Orphanides G, Thomson S, Edmunds JW, et al. 2005. Molecular basis for the recognition of phosphorylated and phosphoacetylated histone H3 by 14-3-3. Mol Cell 20: 199-211.
46. Malumbres M, Barbacid M. 2005. Mammalian cyclin-dependent kinases. Trends Biochem Sci 30: 630-641.
47. Maurer-Stroh S, Dickens NJ, Hughes-Davies L, Kouzarides T, Eisenhaber F, Ponting CP. 2003. The Tudor domain “Royal Family”: Tudor, plant Agenet, Chromo, PWWP and MBT domains. Trends Biochem Sci 28: 69-74.
48. Maxfield FR. 2002. Plasma membrane microdomains. Curr Opin Cell Biol 14: 483-487.
49. McLaughlin S, Aderem A. 1995. The myristoyl-electrostatic switch: A modulator of reversible protein-membrane interactions. Trends Biochem Sci 20: 272-276.
50. Momand J, Zambetti GP, Olson DC, George D, Levine AJ. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1245.
51. Morrison DK. 2012. MAPK kinase pathways. Cold Spring Harb Perspect Biol 4: a011254.
52. Muratani M, Tansey WP. 2003. How the ubiquitin-proteasome system controls transcription. Nat Rev Mol Cell Biol 4: 192-201.
53. Murphy JE, Padilla BE, Hasdemir B, Cottrell GS, Bunnett NW. 2009. Endosomes: A legitimate platform for the signaling train. Proc Natl Acad Sci 106: 17615-17622.
54. Nadolski MJ, Linder ME. 2007. Protein lipidation. FEBS J 274: 5202-5210.
55. Newton AC, Bootman M, Scott JD. 2014. Second messengers. Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a005926.
56. Obenauer JC, Yaffe MB. 2004. Computational prediction of protein-protein interactions. Methods Mol Biol 261: 445-468.
57. Obenauer JC, Cantley LC, Yaffe MB. 2003. Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res 31: 3635-3641.
58. Pei H, Zhang L, Luo K, Qin Y, Chesi M, Fei F, Bergsagel PL, Wang L, You Z, Lou Z. 2011. MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites. Nature 469: 124-128.
59. Perdiz D, Mackeh R, Poüs C, Baillet A. 2011. The ins and outs of tubulin acetylation: More than just a post-translational modification? Cell Signal 23: 763-771.
60. Privé GG, Milburn MV, Tong L, de Vos AM, Yamaizumi Z, Nishimura S, Kim SH. 1992. X-Ray crystal structures of transforming p21 ras mutants suggest a transition-state stabilization mechanism for GTP hydrolysis. Proc Natl Acad Sci 89: 3649-3653.
61. Pullen N, Thomas G. 1997. The modular phosphorylation and activation of p70s6k. FEBS Lett 410: 78-82.
62. Radi R. 2013. Protein tyrosine nitration: Biochemical mechanisms and structural basis of functional effects. Acc Chem Res 46: 550-559.
63. Rasmussen SGF, Devree BT, Zou Y, Kruse AC, Chung KY, Kobilka TS, Thian FS, Chae PS, Pardon E, Calinski D, et al. 2011. Crystal structure of the b2 adrenergic receptor-Gs protein complex. Nature 477: 549-555.
64. Resh MD. 2012. Targeting protein lipidation in disease. Trends Mol Med 18: 206-214.
65. Rhind N, Russell P. 2012. Signaling pathways that regulate cell division. Cold Spring Harb Perspect Biol 4: a005942.
66. Roy S, Plowman S, Rotblat B, Prior IA, Muncke C, Grainger S, Parton RG, Henis YI, Kloog Y, Hancock JF. 2005. Individual palmitoyl residues serve distinct roles in H-ras trafficking, microlocalization, and signaling. Mol Cell Biol 25: 6722-6733.
67. Sever R, Brugge JS. 2014. Signaling in cancer. Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a006098.
68. Sever R, Glass CK. 2013. Signaling by nuclear receptors. Cold Spring Harb Perspect Biol 5: a016709.
69. Siderovski DP, Willard FS. 2005. The GAPs, GEFs, and GDIs of heterotrimeric G-protein a subunits. Int J Biol Sci 1: 51.
70. Slessareva JE, Routt SM, Temple B, Bankaitis VA, Dohlman HG. 2006. Activation of the phosphatidylinositol 3-kinase Vps34 by a G protein a subunit at the endosome. Cell 126: 191-203.
71. Sprang SR. 1997. G protein mechanisms: Insights from structural analysis. Annu Rev Biochem 66: 639-678.
72. Sudakin V, Ganoth D, Dahan A, Heller H, Hershko J, Luca FC, Ruderman JV, Hershko A. 1995. The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis. Mol Biol Cell 6: 185-197.
73. Temple BRS, Jones AM. 2007. The plant heterotrimeric G-protein complex. Annu Rev Plant Biol 58: 249-266.
74. Tesmer JJ, Berman DM, Gilman AG, Sprang SR. 1997. Structure of RGS4 bound to AlF42-activated Gia1: Stabilization of the transition state for GTP hydrolysis. Cell 89: 251-261.
75. Walczak H, Iwai K, Dikic I. 2012. Generation and physiological roles of linear ubiquitin chains. BMC Biol 10: 23.
76. Wang Q, Zhang Y, Yang C, Xiong H, Lin Y, Yao J, Li H, Xie L, Zhao W, Yao Y, et al. 2010. Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux. Science 327: 1004-1007.
77. Weis WI, Kobilka BK. 2008. Structural insights into G-protein-coupled receptor activation. Curr Opin Struct Biol 18: 734-740.
78. Wennerberg K. 2005. The Ras superfamily at a glance. J Cell Sci 118: 843-846.
79. Wise A, Gearing K, Rees S. 2002. Target validation of G-protein coupled receptors. Drug Discov Today 7: 235-246.
80. Wu X, Brewer G. 2012. The regulation of mRNA stability in mammalian cells: 2.0. Gene 500: 10-21.
81. Xu W, Doshi A, Lei M, Eck MJ, Harrison SC. 1999. Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol Cell 3: 629-638.
82. Yaffe MB, Smerdon SJ. 2004. The use of in vitro peptide library screens in the analysis of phosphoserine/threonine-binding domain structure and function. Annu Rev Biophys Biomol Struct 33: 225-244.
83. Zastrow von M, Sorkin A. 2007. Signaling on the endocytic pathway. Curr Opin Cell Biol 19: 436-445.